Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria.


Journal

International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847

Informations de publication

Date de publication:
2020
Historique:
received: 21 09 2019
accepted: 24 12 2019
entrez: 13 3 2020
pubmed: 13 3 2020
medline: 20 6 2020
Statut: epublish

Résumé

Joint arthroplasty has improved the quality of life of patients worldwide, but infections of the prosthesis are frequent and cause significant morbidity. Antimicrobial coatings for implants promise to prevent these infections. We have synthesized nanocapsules of titanium dioxide in amorphous or anatase form containing silver as antibacterial agent and tested their impact on bacterial growth. Furthermore, we explored the possible effect of the nanocapsules on the immune system. First, we studied their uptake into macrophages using a combination of electron microscopy and energy-dispersive spectroscopy. Second, we exposed immune cells to the nanocapsules and checked their activation state by flow cytometry and enzyme-linked immunosorbent assay. Silver-containing titanium dioxide nanocapsules show strong antimicrobial activity against both Our bactericidal silver-containing titanium dioxide nanocapsules fulfill important prerequisites for biomedical use and represent a promising material for the coating of artificial implants.

Sections du résumé

BACKGROUND BACKGROUND
Joint arthroplasty has improved the quality of life of patients worldwide, but infections of the prosthesis are frequent and cause significant morbidity. Antimicrobial coatings for implants promise to prevent these infections.
METHODS METHODS
We have synthesized nanocapsules of titanium dioxide in amorphous or anatase form containing silver as antibacterial agent and tested their impact on bacterial growth. Furthermore, we explored the possible effect of the nanocapsules on the immune system. First, we studied their uptake into macrophages using a combination of electron microscopy and energy-dispersive spectroscopy. Second, we exposed immune cells to the nanocapsules and checked their activation state by flow cytometry and enzyme-linked immunosorbent assay.
RESULTS RESULTS
Silver-containing titanium dioxide nanocapsules show strong antimicrobial activity against both
CONCLUSION CONCLUSIONS
Our bactericidal silver-containing titanium dioxide nanocapsules fulfill important prerequisites for biomedical use and represent a promising material for the coating of artificial implants.

Identifiants

pubmed: 32161457
doi: 10.2147/IJN.S231949
pii: 231949
pmc: PMC7050041
doi:

Substances chimiques

Anti-Bacterial Agents 0
Coated Materials, Biocompatible 0
Nanocapsules 0
titanium dioxide 15FIX9V2JP
Silver 3M4G523W1G
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1267-1281

Informations de copyright

© 2020 Hérault et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Materials (Basel). 2011 Jan 28;4(2):355-367
pubmed: 28879994
Annu Rev Biochem. 2009;78:857-902
pubmed: 19317650
Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):129-38
pubmed: 21640562
Arthroplast Today. 2017 Jun 20;3(2):137-140
pubmed: 28695187
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
Phys Chem Chem Phys. 2012 Apr 28;14(16):5349-62
pubmed: 22422026
Part Fibre Toxicol. 2013 Apr 15;10:15
pubmed: 23587290
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229
Angew Chem Int Ed Engl. 2015 Oct 19;54(43):12597-601
pubmed: 26332072
Immunity. 2015 Jun 16;42(6):1197-211
pubmed: 26084029
Eur J Pharm Biopharm. 2019 Jun;139:253-261
pubmed: 30981947
Int J Pharm. 2018 Jan 15;535(1-2):444-451
pubmed: 29157965
Nanomedicine. 2007 Mar;3(1):95-101
pubmed: 17379174
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
EBioMedicine. 2015 Oct 09;2(11):1697-704
pubmed: 27014740
Colloids Surf B Biointerfaces. 2010 Nov 1;81(1):358-62
pubmed: 20705438
Electrophoresis. 2010 May;31(9):1590-6
pubmed: 20422634
J Bone Joint Surg Am. 2015 Sep 2;97(17):1386-97
pubmed: 26333733
Front Microbiol. 2016 Nov 16;7:1831
pubmed: 27899918
ACS Nano. 2014 Jan 28;8(1):374-86
pubmed: 24341736
Materials (Basel). 2013 Jun 05;6(6):2295-2350
pubmed: 28809275
J Nanobiotechnology. 2017 Jan 6;15(1):5
pubmed: 28061858
Bull Exp Biol Med. 2016 Apr;160(6):831-4
pubmed: 27160885
J Nanobiotechnology. 2015 Oct 05;13:64
pubmed: 26438142
Antivir Ther. 2008;13(2):253-62
pubmed: 18505176
ACS Nano. 2010 Nov 23;4(11):6903-13
pubmed: 20968290
Environ Toxicol Chem. 2014 Mar;33(3):481-92
pubmed: 24273100
Biochem J. 2012 Feb 1;441(3):813-21
pubmed: 22026563
Antimicrob Agents Chemother. 2010 Oct;54(10):4208-18
pubmed: 20660682
Nature. 2002 Dec 19-26;420(6917):885-91
pubmed: 12490963
J Appl Toxicol. 2016 Oct;36(10):1364-73
pubmed: 27225715
J Infect. 2011 Jul;63(1):17-22
pubmed: 21663971
Int Wound J. 2009 Feb;6(1):32-8
pubmed: 19291113
Wounds. 2013 Apr;25(4):84-8
pubmed: 25868055
J R Soc Interface. 2013 Feb 20;10(82):20120939
pubmed: 23427093
Nano Lett. 2012 Aug 8;12(8):4271-5
pubmed: 22765771
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2467-75
pubmed: 26883700
Mater Sci Eng C Mater Biol Appl. 2013 May 1;33(4):2367-75
pubmed: 23498271
Nanoscale. 2013 Aug 21;5(16):7328-40
pubmed: 23821237
Toxicol Lett. 2011 Feb 25;201(1):27-33
pubmed: 21145381
J Appl Toxicol. 2014 Nov;34(11):1209-19
pubmed: 25224607
Clin Microbiol Infect. 2006 Mar;12 Suppl 1:16-23
pubmed: 16445720
PLoS One. 2014 Dec 15;9(12):e114638
pubmed: 25506839
Nanomedicine. 2017 Jan;13(1):11-22
pubmed: 27545103
Orthopedics. 2014 Apr;37(4):257-65
pubmed: 24762833
Part Fibre Toxicol. 2009 Jun 21;6:17
pubmed: 19545397
Chem Rev. 2013 Jul 10;113(7):4708-54
pubmed: 23488929
Toxicol Appl Pharmacol. 1990 Feb;102(2):268-81
pubmed: 2154066
Small. 2018 Jun;14(23):e1800190
pubmed: 29741810
Biomaterials. 2011 Aug;32(24):5706-16
pubmed: 21565401
Nanoscale. 2017 Feb 16;9(7):2492-2504
pubmed: 28150827

Auteurs

Nelly Hérault (N)

Department of Chemistry, University of Fribourg, Fribourg 1700, Switzerland.

Julia Wagner (J)

Department of Medicine, University of Fribourg, Fribourg 1700, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva 1211, Switzerland.
Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland.

Sarah-Luise Abram (SL)

Department of Chemistry, University of Fribourg, Fribourg 1700, Switzerland.

Jérôme Widmer (J)

Department of Medicine, University of Fribourg, Fribourg 1700, Switzerland.

Lenke Horvath (L)

Department of Chemistry, University of Fribourg, Fribourg 1700, Switzerland.

Dimitri Vanhecke (D)

Adolphe Merkle Institute, University of Fribourg, Fribourg 1700, Switzerland.

Carole Bourquin (C)

Department of Medicine, University of Fribourg, Fribourg 1700, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva 1211, Switzerland.
Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland.

Katharina M Fromm (KM)

Department of Chemistry, University of Fribourg, Fribourg 1700, Switzerland.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH